# Meropenem

NDC: 51810-503
Generic name: Meropenem
Labeler / Manufacturer: Qilu Antibiotics Pharmaceutical Co., Ltd.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20241230

FDA application: ANDA216424

## Active ingredients

- MEROPENEM: 1 g/30mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51810-503"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51810-503
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1f9591ed-3a6c-422e-b1be-7b3e4fe5bf3c